title: Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.
authors.affiliation: aService de Pneumologie, CH Yves Le Foll, Saint-Brieuc bINSERM, U 1135, CIMI cSorbonne Universités, UPMC Univ Paris 06 dINSERM, UMRS 1136, Institut Pierre Louis d'épidémiologie et de Santé Publique eAP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie fService de Pneumologie, AP-HP Hôpital Tenon gGRC 04 Theranoscan UPMC Univ Paris 06, Sorbonne Universités hDepartment of Medical Oncology, Groupe hospitalier Pitié-Salpêtrière-Charles Foix, AP-HP iDépartement d'Immunologie, APHP, Hôpital Pitié Salpêtrière, Paris, France. *Gwenaëlle Le Garff and Assia Samri contributed equally to this article.
authors.forename: Gwenaëlle
authors.initials: G
authors.lastname: Le Garff
authors.forename: Assia
authors.initials: A
authors.lastname: Samri
authors.forename: Sidonie
authors.initials: S
authors.lastname: Lambert-Niclot
authors.forename: Sophie
authors.initials: S
authors.lastname: Even
authors.forename: Armelle
authors.initials: A
authors.lastname: Lavolé
authors.forename: Jacques
authors.initials: J
authors.lastname: Cadranel
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Spano
authors.forename: Brigitte
authors.initials: B
authors.lastname: Autran
authors.forename: Anne-Geneviève
authors.initials: AG
authors.lastname: Marcelin
authors.forename: Amélie
authors.initials: A
authors.lastname: Guihot
mesh_terms: D016207:Cytokines / Q000378:metabolism; D015658:HIV Infections / Q000473:pathology*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D007249:Inflammation / Q000473:pathology*; D008175:Lung Neoplasms / Q000188:drug therapy; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D000077594:Nivolumab / Q000008:administration & dosage*; D013601:T-Lymphocytes / Q000276:immunology*; D019562:Viral Load
chemical_list: D016207:Cytokines; D007155:Immunologic Factors; D000077594:Nivolumab